Table 3.

Distribution and proportion of HPV genotypes in ASCUS, L-SIL, and H-SIL cytological lesions

	Cytology result, N (%)
Genotypes	ASCUS (N = 188)	L-SIL (N = 61)	H-SIL (N = 19)	Totala (%)
HR-HPV
HPV16	26 (13.8%)	12 (19.7%)	3 (15.8%)	41 (15.3%)
HPV18	8 (4.3%)	2 (3.3%)	1 (5.3%)	11 (4.1%)
HPV31	31 (16.5%)	7 (11.5%)	2 (10.5%)	40 (14.9%)
HPV33	4 (2.1%)	2 (3.3%)	0 (0%)	6 (2.2%)
HPV35	3 (1.6%)	1 (1.6%)	0 (0%)	4 (1.5%)
HPV39	5 (2.7%)	2 (3.3%)	0 (0%)	7 (2.6%)
HPV45	5 (2.7%)	1 (1.6%)	2 (10.5%)	8 (3%)
HPV51	11 (5.9%)	1 (1.6%)	1 (5.3%)	13 (4.9%)
HPV52	0 (0%)	2 (3.3%)	2 (10.5%)	4 (1.5%)
HPV56	3 (1.6%)	6 (9.8%)	0 (0%)	9 (3.4%)
HPV58	18 (9.6%)	2 (3.3%)	0 (0%)	20 (7.5%)
HPV59	3 (1.6%)	1 (1.6%)	0 (0%)	4 (1.5%)
HPV68	8 (4.3%)	5 (8.2%)	1 (5.3%)	14 (5.2%)
LR-HPV
HPV6	15 (8%)	7 (11.5%)	2 (10.5%)	24 (9%)
HPV11	2 (1.1%)	1 (1.6%)	0 (0%)	3 (1.1%)
HPV42	9 (4.8%)	1 (1.6%)	0 (0%)	10 (3.7%)
HPV44	1 (0.5%)	1 (1.6%)	1 (5.3%)	3 (1.1%)
HPV53	21 (11.2%)	5 (8.2%)	1 (5.3%)	27 (10.1%)
HPV54	6 (3.2%)	1 (1.6%)	2 (10.5%)	9 (3.4%)
HPV55	4 (2.1%)	0 (0%)	1 (5.3%)	5 (1.9%)
HPV61	11 (5.9%)	3 (4.9%)	0 (0%)	14 (5.2%)
HPV66	8 (4.3%)	7 (11.5%)	0 (0%)	15 (5.6%)
HPV70	2 (1.1%)	1 (1.6%)	0 (0%)	3 (1.1%)
HPV73	2 (1.1%)	3 (4.9%)	0 (0%)	5 (1.9%)
HPV81	3 (1.6%)	0 (0%)	0 (0%)	3 (1.1%)
HPV82	6 (3.2%)	0 (0%)	0 (0%)	6 (2.2%)
HPV89	4 (2.1%)	1 (1.6%)	1 (5.3%)	6 (2.2%)
UR-HPV
HPV34	0 (0%)	1 (1.6%)	0 (0%)	1 (0.4%)
HPV62	1 (0.5%)	3 (4.9%)	0 (0%)	4 (1.5%)
HPV83	5 (2.7%)	0 (0%)	1 (5.3%)	6 (2.2%)
HPV84	5 (2.7%)	1 (1.6%)	2 (10.5%)	8 (3%)
HPV90	0 (0%)	1 (1.6%)	0 (0%)	1 (0.4%)
HPV91	1 (0.5%)	0 (0%)	0 (0%)	1 (0.4%)

^aOverall prevalence of individual HPV types in 268 HPV-positive women with available cytology result